JMP Securities Reiterates Market Outperform Rating for STERIS (NYSE:STE)

JMP Securities reiterated their market outperform rating on shares of STERIS (NYSE:STEFree Report) in a report published on Thursday,Benzinga reports. The firm currently has a $265.00 price target on the medical equipment provider’s stock.

A number of other research analysts also recently issued reports on STE. Needham & Company LLC restated a “hold” rating on shares of STERIS in a research note on Monday, April 7th. Piper Sandler raised their target price on shares of STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research report on Monday, February 3rd. Finally, Stephens reaffirmed an “overweight” rating and issued a $240.00 target price on shares of STERIS in a report on Thursday, February 6th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $258.75.

Get Our Latest Stock Report on STE

STERIS Trading Up 1.9 %

Shares of STERIS stock opened at $221.18 on Thursday. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. The company has a fifty day simple moving average of $222.61 and a 200-day simple moving average of $219.62. The stock has a market cap of $21.73 billion, a price-to-earnings ratio of 46.96 and a beta of 0.87. STERIS has a 12-month low of $197.82 and a 12-month high of $248.24.

STERIS (NYSE:STEGet Free Report) last released its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. On average, equities analysts forecast that STERIS will post 9.08 EPS for the current fiscal year.

STERIS Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were issued a dividend of $0.57 per share. This represents a $2.28 annualized dividend and a dividend yield of 1.03%. The ex-dividend date of this dividend was Thursday, February 20th. STERIS’s dividend payout ratio is presently 48.41%.

Hedge Funds Weigh In On STERIS

Institutional investors have recently bought and sold shares of the company. Avalon Trust Co purchased a new stake in shares of STERIS in the fourth quarter valued at about $30,000. Human Investing LLC acquired a new position in STERIS during the 4th quarter worth approximately $31,000. Anfield Capital Management LLC raised its stake in shares of STERIS by 100.0% during the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock worth $37,000 after buying an additional 91 shares in the last quarter. Central Pacific Bank Trust Division lifted its holdings in shares of STERIS by 65.5% in the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock valued at $39,000 after buying an additional 76 shares during the period. Finally, Manchester Capital Management LLC boosted its stake in shares of STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock valued at $44,000 after buying an additional 137 shares in the last quarter. 94.69% of the stock is owned by institutional investors and hedge funds.

About STERIS

(Get Free Report)

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

Further Reading

Analyst Recommendations for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.